Directory
>
Wael Fayad
Wael Fayad
Chairman | Hyland's
New York, New York, United States
Wael Fayad
Summary
Wael Fayad is a seasoned executive in the biopharmaceutical and healthcare sectors, currently serving as a Partner at Hildred Capital Management. With a robust background in business development, clinical trials, and drug development, he has played pivotal roles in multiple organizations, including serving as Chairman at Carlin Consumer Health and Hylands Naturals. Wael's extensive experience spans over two decades, where he has held various leadership positions, including Corporate Vice President at Forest Laboratories and Chairman and CEO at Enumeral Biomedical Holdings. His educational credentials include an MBA from Concordia University and a BSc in Biology from the American University of Beirut. Wael is known for his strategic vision and ability to drive innovation in the pharmaceutical industry. He has a strong interest in emerging technologies and their application in healthcare, aiming to improve patient outcomes through innovative solutions. His leadership style emphasizes collaboration and mentorship, fostering growth in his teams and organizations.
Wael Fayad
Work Experience
Chairman at
Carlin Consumer Health
February 2022 - Present
Chairman at
Hyland's
August 2020 - Present
Board Member at
Crown Laboratories, Inc.
February 2020 - Present
Partner at
Hildred Capital Management
May 2018 - Present
Operating Partner at
Hildred Capital Partners
May 2018 - December 2019
Co-Founder at
Accoy Pharmaceuticals
October 2015 - September 2019
Chairman and CEO at
Enumeral Biomedical Holdings
September 2016 - May 2018
Corporate Vice President, Global Business Development at
Forest Laboratories (now Allergan)
January 2001 - December 2014
Senior Manager, New Products and Business Development at
Schering Plough
June 1998 - December 2000
Brand Manager at
Novartis
May 1993 - May 1998
Wael Fayad
Education
Concordia University, Mba
January 1991 - January 1993
American University of Beirut, Bsc.
January 1986 - January 1989
Frequently Asked Questions about Wael Fayad
What is Wael Fayad email address?
Wael Fayad's primary email address is ******@crownlaboratories.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Wael Fayad work for?
Wael Fayad is a Chairman at Hyland's.
Where Wael Fayad graduated from?
Wael Fayad holds a degree in from Concordia University.
How can I directly contact Wael Fayad?
To contact Wael Fayad directly, you can use the email address ******@crownlaboratories.com. Complete contact information is available upon registration with Muraena.
Is Wael Fayad an immigrant?
Yes, Wael Fayad is an immigrant and currently based in United States
Who is Wael Fayad?
Wael Fayad is a seasoned executive in the biopharmaceutical and healthcare sectors, currently serving as a Partner at Hildred Capital Management. With a robust background in business development, clinical trials, and drug development, he has played pivotal roles in multiple organizations, including serving as Chairman at Carlin Consumer Health and Hylands Naturals. Wael's extensive experience spans over two decades, where he has held various leadership positions, including Corporate Vice President at Forest Laboratories and Chairman and CEO at Enumeral Biomedical Holdings. His educational credentials include an MBA from Concordia University and a BSc in Biology from the American University of Beirut. Wael is known for his strategic vision and ability to drive innovation in the pharmaceutical industry. He has a strong interest in emerging technologies and their application in healthcare, aiming to improve patient outcomes through innovative solutions. His leadership style emphasizes collaboration and mentorship, fostering growth in his teams and organizations.
Wael`s contact details
******@crownlaboratories.com
**********@frx.com
**********@allergan.com
******@hildredcapital.com
Colleagues
Partner
Vice President - Information and Technology
Vice President, Chief Revenue Officer (CRO)
Vice President, Analytics & Insights
Vice President, Quality & Regulatory
Vice President/Controller